Actively Recruiting
The Pathogenesis and Prognostic Factors of Lymphoma
Led by Shanghai Zhongshan Hospital · Updated on 2024-01-12
2000
Participants Needed
1
Research Sites
290 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The aim of this study is to describe the clinical and genetic characteristics of Chinese lymphoma patients, and to explore the relationship between those characteristics and phatogenesis.
CONDITIONS
Official Title
The Pathogenesis and Prognostic Factors of Lymphoma
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients with a pathological diagnosis of lymphoma (including Hodgkin lymphoma and non-Hodgkin lymphoma such as THRLBCL, DLBCL, MZL, CLL/SLL) from 2007 to 2027
- Patients with complete diagnostic, treatment, and follow-up records
- Patients who fully understand and sign the informed consent form (ICF) for participation
You will not qualify if you...
- Patients who refuse to use reliable contraception methods during pregnancy, lactation, or in age-appropriate periods
- Patients with severe mental illness
- Patients considered unsuitable for inclusion by the investigator
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Zhongshan Hospital，Fudan University
Shanghai, Shanghai Municipality, China, 200032
Actively Recruiting
Research Team
P
Peng Liu, Ph.D
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here